Apellis Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Apellis Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 426% to $396,591,000. The net income raised on -$528,628,000 and profit margin reached -133%. Total operating expenses were $855,202,000.
Profit Margin
| 2014 | 0 | -10.78M | |
|---|---|---|---|
| 2015 | 0 | -46.51M | |
| 2016 | 0 | -27.12M | |
| 2017 | 0 | -51.00M | |
| 2018 | 0 | -127.50M | |
| 2019 | 0 | -309.81M | |
| 2020 | 250.64M | -344.87M | -137.59% |
| 2021 | 66.56M | -746.35M | -1121.27% |
| 2022 | 75.42M | -652.17M | -864.7% |
| 2023 | 396.59M | -528.62M | -133.29% |
APLS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 396.59M | 75.42M | 66.56M | 250.64M | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 58.51M | 5.63M | 5.2M | 25.05M | 288.01M | 127.92M | 50.76M | 0 | 0 | 0 |
Gross profit | 338.08M | 69.78M | 61.36M | 225.59M | -288.01M | -127.92M | -50.76M | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 354.38M | 387.23M | 420.86M | 299.92M | 220.96M | 105.28M | 40.30M | 22.97M | 13.73M | 8.37M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 855.20M | 664.39M | 597.64M | 439.32M | 288.01M | 127.92M | 50.76M | 27.28M | 20.08M | 11.29M |
Operating income | -517.12M | -594.61M | -536.27M | -213.72M | -288.01M | -127.92M | -50.76M | -27.28M | -46.57M | -11.29M |
Other income (expenses), net | -9.37M | -56.89M | -209.72M | -129.30M | -16.69M | -25.24K | -239.06K | 157.70K | 57.13K | 62.45K |
Income before tax | -526.49M | -651.50M | -746.00M | -343.02M | -304.70M | -127.50M | -51.00M | -27.12M | -46.51M | -11.23M |
Income tax expense | 2.13M | 669K | 352K | 1.84M | 5.10M | -533.32K | 250.60K | 0 | -26.53M | -443.34K |
Net income | -528.62M | -652.17M | -746.35M | -344.87M | -309.81M | -127.50M | -51.00M | -27.12M | -46.51M | -10.78M |
Earnings per share | ||||||||||
Basic EPS | -4.45 | -6.15 | -8.84 | -4.59 | -4.98 | -2.34 | -3.68 | -1.5 | -2.57 | -0.6 |
Diluted EPS | -4.45 | -6.15 | -8.84 | -4.59 | -4.98 | -2.34 | -3.68 | -1.5 | -2.57 | -0.6 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |